How is mRNA technology being applied beyond COVID-19 vaccines?
The technology that saved millions from COVID is now targeting cancer, heart disease, and rare genetic disorders.
The answer
Messenger RNA technology, proven by the Pfizer-BioNTech and Moderna COVID-19 vaccines, is being adapted for numerous medical applications. Moderna's mRNA-4157 (V940), a personalized cancer vaccine used alongside immunotherapy drug Keytruda, showed a 44% reduction in melanoma recurrence in Phase 2 trials and entered Phase 3 trials in 2024. BioNTech is developing individualized mRNA cancer vaccines targeting patient-specific tumor mutations. Moderna is also testing mRNA vaccines against respiratory syncytial virus, influenza, and cytomegalovirus simultaneously. Beyond vaccines, mRNA therapies are being developed for rare genetic diseases - Moderna's mRNA-3927 treats propionic acidemia by instructing cells to produce missing enzymes. The technology fundamentally transforms cells into drug factories.
Source: Nature Reviews Drug Discovery
- mRNA
- cancer vaccines
- biotechnology
More from Science & Discovery
- Why is the sky blue?
- How do trees communicate?
- Why do we yawn?
- What happens inside a black hole?
- Why does honey never spoil?
- How does a caterpillar turn into a butterfly?